🔎 Trials Near Me

Home › Dermatitis › Alabama

Pag-aaral pangklinika para sa Dermatitis sa Alabama

6 pag-aaral para sa Dermatitis ang naghahanap ng mga kalahok sa mga site sa Alabama.

Mga Lungsod sa Alabama

Opisyal na teksto ng pag-aaral (English)

A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema

  • Cahaba Dermatology & Skin Health Center, Birmingham
Nagre-recruitPhase 3
Edad 12 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07765888

First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis

  • Cahaba Dermatology & Skin Health Center, LLC, Birmingham
Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT07527923

Roflumilast Cream 0.3% for Moderate to Severe Atopic Dermatitis

  • Arcutis Site 324, Birmingham
Nagre-recruitPhase 3
Edad 6 pataas · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT07916480

A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe Eczema

  • AllerVie Clinical Research, Birmingham
  • Cahaba Dermatology & Skin Health Center, Birmingham
Nagre-recruitPhase 3
Edad 12 pataas · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT07783425

Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis

  • Novartis Investigative Site, Birmingham
  • Novartis Investigative Site, Birmingham
Nagre-recruitPhase 2
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT06947993

A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis

  • AllerVie Clinical Research, Birmingham
  • Cahaba Dermatology and Skin Health Center, Birmingham
Nagre-recruitPhase 2
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT07599813

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.